Pharmafile Logo
Pharmafocus logo
Advanced Search

cell and gene therapies

Showing 3 posts of 3 posts found.

partnership

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

October 30, 2025
Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership

Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …

News

ElevateBio announced $401m in Series D financing for cell and gene therapies

May 25, 2023
Sales and Marketing ElevateBio, Financing, cell and gene therapies

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …

News
novartis_iobmr

Up to 120 jobs set to go as Novartis closes down Cell and Gene Therapies unit

September 1, 2016
Manufacturing and Production, Research and Development CAR-T, Novartis, cart, cell and gene therapies

News has emerged that Novartis plans to close down its Cell and Gene Therapies unit, with up to 120 workers …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026